PubRank

Rémy Burcelin

Author PubWeight™ 86.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 14.12
2 Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008 10.74
3 The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 2003 4.11
4 Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008 2.77
5 Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011 2.25
6 Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 2004 2.11
7 Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009 2.05
8 Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 2005 2.01
9 Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci U S A 2012 2.00
10 Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol 2013 1.87
11 Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006 1.83
12 Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 2006 1.81
13 Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008 1.48
14 Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 2004 1.38
15 Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003 1.38
16 Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 2010 1.26
17 Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 2008 1.25
18 Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 2011 1.25
19 GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. Mol Cell Endocrinol 2007 1.24
20 Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008 1.24
21 Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology 2004 1.10
22 Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 2004 1.08
23 Transcript profiling suggests that differential metabolic adaptation of mice to a high fat diet is associated with changes in liver to muscle lipid fluxes. J Biol Chem 2004 1.08
24 Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain. Endocrinology 2006 1.08
25 Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 2006 1.08
26 Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 2011 1.05
27 GLP-1 effects on islets: hormonal, neuronal, or paracrine? Diabetes Care 2013 1.02
28 Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 2007 1.01
29 Polycyclic aromatic hydrocarbons potentiate high-fat diet effects on intestinal inflammation. Toxicol Lett 2010 0.98
30 Cellular and molecular mechanisms of adipose tissue plasticity in muscle insulin receptor knockout mice. Endocrinology 2003 0.95
31 PPARγ ligands switched high fat diet-induced macrophage M2b polarization toward M2a thereby improving intestinal Candida elimination. PLoS One 2010 0.95
32 Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes 2005 0.95
33 Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology 2006 0.92
34 GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud 2011 0.91
35 FXR-deficiency confers increased susceptibility to torpor. FEBS Lett 2007 0.91
36 Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic β-cell impairments in type 2 diabetes. Cell Signal 2012 0.91
37 Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice. Am J Physiol Endocrinol Metab 2013 0.90
38 The gut microbiota profile is associated with insulin action in humans. Acta Diabetol 2012 0.89
39 Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Mol Metab 2013 0.88
40 Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable. Diabetes 2013 0.88
41 Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One 2013 0.86
42 Developmental androgen excess disrupts reproduction and energy homeostasis in adult male mice. J Endocrinol 2013 0.86
43 Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS One 2011 0.86
44 Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ. Diabetes 2011 0.85
45 High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogens. PLoS One 2012 0.83
46 Normal insulin sensitivity during the late preclinical stage of type 1 diabetes. Diabetes Care 2004 0.83
47 The antidiabetic gutsy role of metformin uncovered? Gut 2013 0.79
48 Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins. J Clin Endocrinol Metab 2014 0.78
49 Lipid-induced peroxidation in the intestine is involved in glucose homeostasis imbalance in mice. PLoS One 2011 0.77
50 An adiponectin-like molecule with antidiabetic properties. Endocrinology 2009 0.77
51 Interrelationship between lymphocytes and leptin in fat depots of obese mice revealed by changes in nutritional status. J Physiol Biochem 2015 0.77
52 Hawthorn evokes a potent anti-hyperglycemic capacity in streptozotocin-induced diabetic rats. J Herb Pharmacother 2003 0.76
53 [GLP-1 and cerebral detection of glucose, a key mechanism for the regulation of glucose homeostasis]. Med Sci (Paris) 2006 0.76
54 A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. Cell Metab 2017 0.75
55 [New insights into adipose cell biology]. Bull Acad Natl Med 2013 0.75
56 [Mitochondrial dysfunction and insulino-resistance: no causal link]. Med Sci (Paris) 2008 0.75
57 Erratum: Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals. Sci Rep 2016 0.75